ArticleJournal for immunotherapy of cancer2022

Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors.

Razvan Cristescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.